Expression of CD28 on CD8+ and CD4+ lymphocytes during HIV infection. 1994

A Caruso, and A Cantalamessa, and S Licenziati, and L Peroni, and E Prati, and F Martinelli, and A D Canaris, and S Folghera, and R Gorla, and A Balsari
Institute of Microbiology, University of Brescia, Italy.

CD28 interaction with B7 molecules, expressed on the membranes of antigen-presenting cells, co-stimulates cytokine production, T-cell proliferation and generation of cytotoxic lymphocytes. The expression of CD28 markers on CD4+ and CD8+ lymphocytes was studied in a group of subjects at various stages of HIV infection. A reduction in the percentage of CD28-bearing CD4+ and CD8+ cell subsets was observed during the asymptomatic stage of the disease. This reduction was more pronounced in AIDS than in non-AIDS patients. At the same time, an increase in the absolute CD8+CD28- cell number (greater in stage A than in stage B and C subjects) was observed in HIV-infected patients. The finding of an altered pattern of CD28 expression on T cells might per se explain certain early defects in the cytokine pattern and in the immune response peculiar to HIV-infected patients.

UI MeSH Term Description Entries
D005434 Flow Cytometry Technique using an instrument system for making, processing, and displaying one or more measurements on individual cells obtained from a cell suspension. Cells are usually stained with one or more fluorescent dyes specific to cell components of interest, e.g., DNA, and fluorescence of each cell is measured as it rapidly transverses the excitation beam (laser or mercury arc lamp). Fluorescence provides a quantitative measure of various biochemical and biophysical properties of the cell, as well as a basis for cell sorting. Other measurable optical parameters include light absorption and light scattering, the latter being applicable to the measurement of cell size, shape, density, granularity, and stain uptake. Cytofluorometry, Flow,Cytometry, Flow,Flow Microfluorimetry,Fluorescence-Activated Cell Sorting,Microfluorometry, Flow,Cell Sorting, Fluorescence-Activated,Cell Sortings, Fluorescence-Activated,Cytofluorometries, Flow,Cytometries, Flow,Flow Cytofluorometries,Flow Cytofluorometry,Flow Cytometries,Flow Microfluorometries,Flow Microfluorometry,Fluorescence Activated Cell Sorting,Fluorescence-Activated Cell Sortings,Microfluorimetry, Flow,Microfluorometries, Flow,Sorting, Fluorescence-Activated Cell,Sortings, Fluorescence-Activated Cell
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D015496 CD4-Positive T-Lymphocytes A critical subpopulation of T-lymphocytes involved in the induction of most immunological functions. The HIV virus has selective tropism for the T4 cell which expresses the CD4 phenotypic marker, a receptor for HIV. In fact, the key element in the profound immunosuppression seen in HIV infection is the depletion of this subset of T-lymphocytes. T4 Cells,T4 Lymphocytes,CD4-Positive Lymphocytes,CD4 Positive T Lymphocytes,CD4-Positive Lymphocyte,CD4-Positive T-Lymphocyte,Lymphocyte, CD4-Positive,Lymphocytes, CD4-Positive,T-Lymphocyte, CD4-Positive,T-Lymphocytes, CD4-Positive,T4 Cell,T4 Lymphocyte
D015658 HIV Infections Includes the spectrum of human immunodeficiency virus infections that range from asymptomatic seropositivity, thru AIDS-related complex (ARC), to acquired immunodeficiency syndrome (AIDS). HTLV-III Infections,HTLV-III-LAV Infections,T-Lymphotropic Virus Type III Infections, Human,HIV Coinfection,Coinfection, HIV,Coinfections, HIV,HIV Coinfections,HIV Infection,HTLV III Infections,HTLV III LAV Infections,HTLV-III Infection,HTLV-III-LAV Infection,Infection, HIV,Infection, HTLV-III,Infection, HTLV-III-LAV,Infections, HIV,Infections, HTLV-III,Infections, HTLV-III-LAV,T Lymphotropic Virus Type III Infections, Human
D016130 Immunophenotyping Process of classifying cells of the immune system based on structural and functional differences. The process is commonly used to analyze and sort T-lymphocytes into subsets based on CD antigens by the technique of flow cytometry. Lymphocyte Immunophenotyping,Lymphocyte Subtyping,Immunologic Subtyping,Immunologic Subtypings,Lymphocyte Phenotyping,Subtyping, Immunologic,Subtypings, Immunologic,Immunophenotyping, Lymphocyte,Immunophenotypings,Immunophenotypings, Lymphocyte,Lymphocyte Immunophenotypings,Lymphocyte Phenotypings,Lymphocyte Subtypings,Phenotyping, Lymphocyte,Phenotypings, Lymphocyte,Subtyping, Lymphocyte,Subtypings, Lymphocyte
D018106 CD28 Antigens Costimulatory T-LYMPHOCYTE receptors that have specificity for CD80 ANTIGEN and CD86 ANTIGEN. Activation of this receptor results in increased T-cell proliferation, cytokine production and promotion of T-cell survival. Antigens, CD28,CD28 Antigen,T-Cell-Specific Surface Glycoprotein CD28,TP44 Receptor,Antigen, CD28,Receptor, TP44,T Cell Specific Surface Glycoprotein CD28
D018414 CD8-Positive T-Lymphocytes A critical subpopulation of regulatory T-lymphocytes involved in MHC Class I-restricted interactions. They include both cytotoxic T-lymphocytes (T-LYMPHOCYTES, CYTOTOXIC) and CD8+ suppressor T-lymphocytes. Suppressor T-Lymphocytes, CD8-Positive,T8 Cells,T8 Lymphocytes,CD8-Positive Lymphocytes,Suppressor T-Cells, CD8-Positive,CD8 Positive Lymphocytes,CD8 Positive T Lymphocytes,CD8-Positive Lymphocyte,CD8-Positive Suppressor T-Cell,CD8-Positive Suppressor T-Cells,CD8-Positive Suppressor T-Lymphocyte,CD8-Positive Suppressor T-Lymphocytes,CD8-Positive T-Lymphocyte,Cell, T8,Cells, T8,Lymphocyte, CD8-Positive,Lymphocyte, T8,Lymphocytes, CD8-Positive,Lymphocytes, T8,Suppressor T Cells, CD8 Positive,Suppressor T Lymphocytes, CD8 Positive,Suppressor T-Cell, CD8-Positive,Suppressor T-Lymphocyte, CD8-Positive,T-Cell, CD8-Positive Suppressor,T-Cells, CD8-Positive Suppressor,T-Lymphocyte, CD8-Positive,T-Lymphocyte, CD8-Positive Suppressor,T-Lymphocytes, CD8-Positive,T-Lymphocytes, CD8-Positive Suppressor,T8 Cell,T8 Lymphocyte

Related Publications

A Caruso, and A Cantalamessa, and S Licenziati, and L Peroni, and E Prati, and F Martinelli, and A D Canaris, and S Folghera, and R Gorla, and A Balsari
March 1994, Journal of acquired immune deficiency syndromes,
A Caruso, and A Cantalamessa, and S Licenziati, and L Peroni, and E Prati, and F Martinelli, and A D Canaris, and S Folghera, and R Gorla, and A Balsari
July 2005, AIDS (London, England),
A Caruso, and A Cantalamessa, and S Licenziati, and L Peroni, and E Prati, and F Martinelli, and A D Canaris, and S Folghera, and R Gorla, and A Balsari
May 2008, AIDS (London, England),
A Caruso, and A Cantalamessa, and S Licenziati, and L Peroni, and E Prati, and F Martinelli, and A D Canaris, and S Folghera, and R Gorla, and A Balsari
April 2004, Experimental gerontology,
A Caruso, and A Cantalamessa, and S Licenziati, and L Peroni, and E Prati, and F Martinelli, and A D Canaris, and S Folghera, and R Gorla, and A Balsari
January 2013, Terapevticheskii arkhiv,
A Caruso, and A Cantalamessa, and S Licenziati, and L Peroni, and E Prati, and F Martinelli, and A D Canaris, and S Folghera, and R Gorla, and A Balsari
June 1995, AIDS (London, England),
A Caruso, and A Cantalamessa, and S Licenziati, and L Peroni, and E Prati, and F Martinelli, and A D Canaris, and S Folghera, and R Gorla, and A Balsari
August 1992, AIDS (London, England),
A Caruso, and A Cantalamessa, and S Licenziati, and L Peroni, and E Prati, and F Martinelli, and A D Canaris, and S Folghera, and R Gorla, and A Balsari
February 1996, Pediatric AIDS and HIV infection,
A Caruso, and A Cantalamessa, and S Licenziati, and L Peroni, and E Prati, and F Martinelli, and A D Canaris, and S Folghera, and R Gorla, and A Balsari
August 2015, Parasitology research,
A Caruso, and A Cantalamessa, and S Licenziati, and L Peroni, and E Prati, and F Martinelli, and A D Canaris, and S Folghera, and R Gorla, and A Balsari
August 1997, European journal of immunology,
Copied contents to your clipboard!